Accelerate Your Drug Discovery Program
with a Consultative Partner


Drug Discovery Consulting: A Drug Discovery Consultative Approach
Drug discovery and development present a challenging landscape, but you don't have to navigate it alone. As your partner, we provide a consultative approach that leverages our years of expertise and scientific excellence to deliver personalized insights that illuminate your path. Our collaborative approach expedites your journey, proactively minimizing potential risks and maximizing your chances of success.
Why Partner with Inotiv for Consultative Discovery?
Inotiv goes beyond the simple drug discovery consulting. We offer a consultative partnership, leveraging our deep industry experience, scientific leadership, and attentive, decisive advice to uncover key insights into your target pathway. We design, run, and interpret study results that identify potential risks for your drug candidate, empowering you to make informed decisions before significant investment.
As a true extension of your team, you’ll benefit from:
- Tailored Consultative Solutions: We don't just provide services; we engage in a consultative process to understand your team's goals and needs. Together, we craft a preclinical discovery and development program that precisely aligns with your objectives.
- Early Consultative Insights: Our exploratory preclinical safety evaluations aren't just tests; they're consultative analyses that reveal critical dose-exposure relationships and potential adverse effects, enabling swift, informed decision-making.
- Dedicated Consultative Partnership: Inotiv's commitment to scientific continuity means you'll work with a dedicated team of experts who provide ongoing consultative guidance and support throughout your compound's development journey.
Understanding Your Discovery Program

Business Model & Program Goals
- Disease Indication
- Competitive Landscape
- Target Product Profile
- Therapeutic Modality
- Key Milestones
- Develop, Partner, or Sell

Is Target Validated or Novel
- In Vitro Pharmacology/Target Engagement
- Expression in Target Tissue
- Genetically Engineered Model
- Proof of Pharmacology & Mechanism

Therapeutic Approach
- Active Chemistry
- Mechanism of Action
- Potency & Selectivity
- DMPK Optimization
- PK-PD and PK Prediction

Model Selection & Translation
- Animal Model(s) Characterization
- Disease/Target Biomarker Plan
- Disease Pathways Analysis (Proteomics)
- Quantitative Pathology

Safety Assessment Strategy
- Species Selection
- Formulation
- Dose Proportionality & Sex Differences
- TK Modeling
- Margin of Safety
- Mechanistic Toxicology

and Pathways Analysis Proteomic Target
and Pathways Analysis Proteomic quantification of any protein, in any sample, with any modification, without antibodies. Inotiv’s high resolution global and targeted proteomics that can characterize disease pathways and drug target systems in research models.
Copyright © 2025 Inotiv. All Rights Reserved.